KMTS

Kestra Medical Technologies, Ltd. Common Stock

KMTS
Closed
$26.95
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Country

US

CEO

Mr. Brian Webster

IPO date

2025

Employees

330

ISIN

BMG524411052

Website

-

Key stats

Open

$27.80

Volume

387.13K

Market cap

$1.56B

Prev. close

$26.69

Impl / hst vl

-

Open interest

$0.00

$26.18

Day’s Range

$27.80

$17.34

52W Range

$28.81

Valuation

33
Valuation score
Overvalued
P/E
-
P/S
-
P/B
5.68
Current ratio
7.32
Debt / Equity
-0.86
ROE
-68.83%
Gross margin
52.57%
Income growth
4.21%
FCF growth
9.98

Analysts estimates

Consensus rating
Strong buy

The average rating from top 6 analysts indicates that stock may significantly outperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$27.95
The top 7 analysts forecasts that 12-month price may increase by 3.70%, with a low of $17.17 and a high of $33.60
$17.17
Low
$27.95
Avg
$33.60
High
Current price

Earnings

Q1 ‘26 revenue
$24.55M
Q1 ‘26 net income
-$34.17M
Revenue
Net income
Previous EPS
-$0.64
Estimate EPS
-$0.61
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply